Show simple item record

dc.contributor.authorThelwell, Craigen
dc.contributor.authorRigsby, Peteren
dc.contributor.authorLongstaff, Colinen
dc.contributor.authorWorld Health Organization. Biologicals Uniten
dc.contributor.authorWHO Expert Committee on Biological Standardization (‎2010 : Geneva, Switzerland)‎en
dc.coverage.spatialGeneva
dc.date.accessioned2012-06-17T01:44:23Z
dc.date.available2012-06-17T01:44:23Z
dc.date.created2010en
dc.date.issued2010en
dc.identifier.govdocWHO/BS/10.2144en
dc.identifier.urihttps://apps.who.int/iris/handle/10665/70517
dc.descriptionWHO/BS/10.2144en
dc.description27 p.en
dc.descriptionEnglish onlyen
dc.language.isoenen
dc.publisherWorld Health Organization
dc.publisherWorld Health Organization
dc.subject.meshComplement C1 Inhibitor Proteinen
dc.subject.meshChromogenic Compoundsen
dc.subject.otherPharmaceuticals and Biologicalsen
dc.titleAn international collaborative study to establish the 1st [‎first]‎ WHO international standards for C1-inhibitor, plasma and concentrate / by Craig Thelwell, Peter Rigsby and Colin Longstaffen
dc.subject.meshqualifierstandardsen


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record